FDA Approves Relenza For The Prevention Of Influenza A And B In Adults And Children
Thu, 30 Mar 2006 11:00 PM EST
... The Food and Drug Administration (FDA) today approved the use of Relenza (zanamivir for inhalation) for prevention (prophylaxis) of influenza (flu) in adults and children 5 years of age and older. Relenza, an antiviral medication, was previously approved for the treatment of influenza A and B virus infections in adults and children... click link for more info. ...
Related Topics
- Influenza
- Zanamivir
- Older Adults
- Injury/ Injury Prevention
- Prevention
- Thalidomide
- Disease Prevention
- Influenza and Colds
- Safety Issues
- Heart Diseases--Prevention
- Avian Influenza
- STD Prevention
- Tacrolimus ointment
- Mammography
- Influenza Virus Vaccine
- Wellness Screening: Adults
- Kidney Stones in Adults
- Brain tumor - adults
- Nephrotic Syndrome in Adults
- Influenza Vaccines

Not Signed In -

